8CZG image
Deposition Date 2022-05-24
Release Date 2023-01-11
Last Version Date 2024-11-20
Entry Detail
PDB ID:
8CZG
Keywords:
Title:
Human BAK in complex with the dF3 peptide
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.99 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Bcl-2 homologous antagonist/killer
Gene (Uniprot):BAK1
Mutagens:C166S
Chain IDs:A, B, C, D
Chain Length:170
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:dF3 peptide
Chain IDs:E, F, G, H
Chain Length:25
Number of Molecules:4
Biological Source:synthetic construct
Primary Citation
Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.
Structure 31 265 281.e7 (2023)
PMID: 36706751 DOI: 10.1016/j.str.2023.01.001

Abstact

Apoptosis is important for development and tissue homeostasis, and its dysregulation can lead to diseases, including cancer. As an apoptotic effector, BAK undergoes conformational changes that promote mitochondrial outer membrane disruption, leading to cell death. This is termed "activation" and can be induced by peptides from the human proteins BID, BIM, and PUMA. To identify additional peptides that can regulate BAK, we used computational protein design, yeast surface display screening, and structure-based energy scoring to identify 10 diverse new binders. We discovered peptides from the human proteins BNIP5 and PXT1 and three non-native peptides that activate BAK in liposome assays and induce cytochrome c release from mitochondria. Crystal structures and binding studies reveal a high degree of similarity among peptide activators and inhibitors, ruling out a simple function-determining property. Our results shed light on the vast peptide sequence space that can regulate BAK function and will guide the design of BAK-modulating tools and therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures